CBDL (CBD Life Sciences) ROCE %: -15.52% (As of Sep. 2015)


What is CBD Life Sciences ROCE %?

CBD Life Sciences CBDL ROCE % is -15.52% as of Sep. 2015.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CBD Life Sciences's annualized ROCE % for the quarter that ended in Sep. 2015 was -15.52%.

CBD Life Sciences  (OTCPK:CBDL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CBD Life Sciences ROCE % Related Terms

CBD Life Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences ROCE % Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
ROCE %
-11.13 -34.48 -70.42 -137.96

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -323.56 -21.79 -14.01 -20.69 -15.52

CBD Life Sciences ROCE % Calculation

CBD Life Sciences's annualized ROCE % for the fiscal year that ended in Dec. 2014 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2014 )  (A: Dec. 2013 )(A: Dec. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2014 )  (A: Dec. 2013 )(A: Dec. 2014 )
=-0.765/( ( (0.663 - 0.115) + (0.632 - 0.071) )/ 2 )
=-0.765/( (0.548+0.561)/ 2 )
=-0.765/0.5545
=-137.96 %

CBD Life Sciences's ROCE % of for the quarter that ended in Sep. 2015 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2015 )  (Q: Jun. 2015 )(Q: Sep. 2015 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2015 )  (Q: Jun. 2015 )(Q: Sep. 2015 )
=-0.088/( ( (0.624 - 0.045) + (0.621 - 0.066) )/ 2 )
=-0.088/( ( 0.579 + 0.555 )/ 2 )
=-0.088/0.567
=-15.52 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2015) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -15.52% mean?
CBD Life Sciences (CBDL) has a ROCE % of -15.52% as of Sep. 2015.
Is CBD Life Sciences' ROCE % too high?
CBD Life Sciences' current ROCE % is -15.52%.
How does CBD Life Sciences' ROCE % compare to QPAG and ADGO?
CBD Life Sciences' ROCE % of -15.52% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CBD Life Sciences's current ROCE % is -15.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current ROCE % of -15.52%. The current ROCE % is -15.52%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current ROCE % is -15.52% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.